Conventional imaging is suboptimal at evaluating disease status in renal cell carcinoma (RCC) because of poor sensitivity. Furthermore, there is an unmet need for the treatment of metastatic RCC, both ...
Background: Sunitinib malate is an oral, multitargeted tyrosine kinase inhibitor that has demonstrated superior efficacy over interferon (IFN)-α in a phase III trial in first-line, metastatic renal ...
Many patients with localized node-negative renal cell carcinoma (RCC) are elderly with competing comorbidities. Their overall survival benefit after surgical treatment is unknown. We reviewed cases in ...
Specificity of radiographic lymphadenopathy for lymph node metastasis in renal cell carcnioma. This is an ASCO Meeting Abstract from the 2015 Genitourinary Cancers Symposium. This abstract does not ...
Clear cell renal cell carcinoma (RCC) is the most common histological subtype of malignant kidney tumors. Clinically, clear cell RCC cannot be distinguished from other histological RCC classes based ...
Emerging treatments for renal cell carcinoma (RCC), including kinase inhibitors, checkpoint inhibitors, and combinations of these new agents, are improving outcomes for patients A need for biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results